Piper Sandler analyst Korinne Wolfmeyer maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $21 to $24.
- Headlines
- Piper Sandler Maintains Neutral on Hims & Hers Health, Raises Price Target to $24
Piper Sandler Maintains Neutral on Hims & Hers Health, Raises Price Target to $24
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
15:35
Intel will launch the second generation of the Xe-HPG B series car-mounted discrete graphics cards.
INTEL-T0.00%
15:34
Wistron’s sales in December reached 105.65 billion New Taiwan dollars, a year-on-year increase of 41.4%.
15:31
Jeju Aviation announced a reduction of over 1,900 flights in the first quarter to ensure flight safety.